Development of the molecular imaging and the therapy of the unstable plaque targeting activated macrophages
Development of the molecular imaging and the therapy of the unstable plaque targeting activated macrophages
批准号:
23591105
负责人:
MIYATA MASAAKI
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The folic acid receptor beta (FR-beta) attracts attention as a marker of activated macrophages. We found that the activated macrophage which expressed FR-beta was present in the arteriosclerosis lesion of the arteriosclerosis model mouse. We administrated the recombinant immunotoxin which coupled Pseudomonas aeruginosa toxin to anti-FR-beta monoclonal antibody into the arteriosclerosis model mice, selectively killed the activated macrophages, and demonstrated that it reduced arteriosclerotic lesion.In addition, we established a sandwich ELISA assay using anti-FR-beta monoclonal antibody and measured the soluble FR-beta concentration of human serum. The patients with aortic aneurysms showed a higher serum FR-beta level compared with the normal control. The measurement of the soluble FR-beta concentration is suggested to be useful for the diagnosis of atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Topic 10「動脈硬化治療の最前線」Novel therapy for atherosclerosis targeting folate receptorβ-expressing activated macrophages
主题10“动脉硬化治疗的最前沿”以表达叶酸受体β的活化巨噬细胞为靶点的动脉粥样硬化新疗法
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Miyata M, Furusho Y, Tei C]
通讯作者:
Tei C
Novel therapy for atherosclerosis targeting folate receptor β-expressing activated macrophages
针对表达叶酸受体β的激活巨噬细胞的动脉粥样硬化新疗法
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Miyata M, Furusho Y, Tei C]
通讯作者:
Tei C
Targeting FRβ-expressing macrophages reduced atherosclerosis in apolipoprotein-E-deficient mice
靶向表达 FRβ 的巨噬细胞可减少载脂蛋白 E 缺陷小鼠的动脉粥样硬化
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Furusho Y, Miyata M, Akasaki Y, Hamada N, Miyauchi T, Ikeda Y, Hamasaki S, Tei C]
通讯作者:
Tei C
Therapeutic agent for arteriosclerosis or arteriosclerotic diseae, and diagnositic agent for arteriosclerosis or arteriosclerosic disease
动脉硬化或动脉硬化疾病的治疗剂以及动脉硬化或动脉硬化疾病的诊断剂
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[]
通讯作者:
Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cells.
吉非替尼和厄洛替尼对H23肺癌细胞凋亡和c-MYC表达的影响。
DOI:
--
发表时间:
2013
期刊:
Anticancer Res
影响因子:
2
作者:
[Suenaga M, Yamamoto M, Tabata S, Itakura S, Miyata M, Hamasaki S, Furukawa T]
通讯作者:
Furukawa T
共 21 条
海外基金